RxSight (RXST) Other Non Operating Income (2023)
RxSight posted quarterly Other Non Operating Income of -$1.4 million for Q3 2023, down 288.67% on a QoQ basis from -$362000.0 in Q2 2023.
RxSight (RXST) has 1 years of Other Non Operating Income data on file, last reported at -$1.4 million in Q3 2023.
- For the quarter ending Q3 2023, Other Non Operating Income changed N/A year-over-year to -$1.4 million; the trailing twelve-month figure through Sep 2024 stood at -$1.4 million (up 20.46% YoY), and the FY2023 full-year result was -$1.8 million, changed N/A from the prior year.
- Other Non Operating Income for Q3 2023 stood at -$1.4 million, down from -$362000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at -$362000.0 in Q2 2023 and bottomed at -$1.4 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | -362,000.00 |